SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2
Shavali Shaik(Brigham and Women's Hospital), Wenyi Wei(Beth Israel Deaconess Medical Center), Wolfram Goessling(Brigham and Women's Hospital), Gregory M. Frechette(Brigham and Women's Hospital), Guido Fadda(University of Messina), Vânia Nosé(Massachusetts General Hospital), Trista E. North(Brigham and Women's Hospital), Carmelo Nucera(Beth Israel Deaconess Medical Center), Lauren Harris(Brigham and Women's Hospital), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), Hidefumi Fukushima(Brigham and Women's Hospital), Amjad Husain(Brigham and Women's Hospital), Daming Gao(Westlake University), Maija Garnaas(Brigham and Women's Hospital), Jack Lawler(Beth Israel Deaconess Medical Center), Lixin Wan(Yangtze University), Hiroyuki Inuzuka(Beth Israel Deaconess Medical Center)
Cited by 94
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
|Science|2023|618
Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
|Cold Spring Harbor Perspectives in Medicine|2012|546